Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-117142
Filing Date
2024-10-24
Accepted
2024-10-24 18:23:30
Documents
2
Period of Report
2024-10-14

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 8008
2 EX-24 axsm-ex24.htm EX-24 11141
  Complete submission text file 0000950170-24-117142.txt   20576
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE WORLD TRDE CENTER 22ND FLOOR NEW YORK NY 10007
Business Address
Maizel Ari (Reporting) CIK: 0002042289 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37635 | Film No.: 241393736